Elena Moreno-Castillo

Elena Moreno-Castillo

Auto-generated profile, based on publicly available information

Elena Moreno-Castillo

Center for Natural Products Research, Faculty of Chemistry, University of Havana, La Habana, Cuba

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2019 in ACS Omega
Verified
Journal Article
Open access
FVFidel E. Morales Vicente
Fidel E. Morales Vicente
MGMelaine González-Garcia
Melaine González-Garcia
EPErbio Diaz Pico
Erbio Diaz Pico
EMElena Moreno-Castillo
Elena Moreno-Castillo
HGHilda E. Garay
Hilda E. Garay
AOAnselmo J. Otero-González
Anselmo J. Otero-González
Following the information obtained by a rational design study, a cyclic and helical-stabilized analogue of the peptide Cm-p5 was synthetized. The cyclic monomer showed an increased activity in vitro against Candida albicans and Candida parapsilosis, compared to Cm-p5. Initially, 14 mutants of Cm-p5 were synthesized following a rational design to improve the antifungal activity and pharmacological properties. Antimicrobial testing showed that the activity was lost in each of these 14 analogues, suggesting, as a main conclusion, that a Glu–His salt bridge could stabilize Cm-p5 helical conformation during the interaction with the plasma membrane. A derivative, obtained by substitution of Glu and His for Cys, was synthesized and oxidized with the generation of a cyclic monomer with improved antifungal activity. In addition, two dimers were generated during the oxidation procedure, a parallel and antiparallel one. The dimers showed a helical secondary structure in water, whereas the cyclic monomer only showed this conformation in SDS. Molecular dynamic simulations confirmed the helical stabilizations for all of them, therefore indicating the possible essential role of the Glu–His salt bridge. In addition, the antiparallel dimer showed a moderate activity against Pseudomonas aeruginosa and a significant activity against Listeria monocytogenes. Neither the cyclic monomer nor the dimers were toxic against macrophages or THP-1 human cells. Due to its increased capacity for fungal control compared to fluconazole, its low cytotoxicity, together with a stabilized α-helix and disulfide bridges, that may advance its metabolic stability, and in vivo activity, the new cyclic Cm-p5 monomer represents a potential systemic antifungal therapeutic candidate.

25 February 2021 in SN Applied Sciences
Verified
Journal Article
Open access
PDF file
JCJulieta Coro-Bermello
Julieta Coro-Bermello
ELErnesto R. López-Rodríguez
Ernesto R. López-Rodríguez
JAJavier E. Alfonso-Ramos
Javier E. Alfonso-Ramos
DADayana Alonso
Dayana Alonso
GOGerardo M. Ojeda-Carralero
Gerardo M. Ojeda-Carralero
EMElena Moreno-Castillo
Elena Moreno-Castillo
Chagas disease is a serious health problem in Central and South America for which effective treatment is not currently available. This illness is caused by the protozoa Trypanosoma cruzi, a species that relies on a thiol-based metabolism to regulate oxidative stress. Trypanothione reductase enzyme plays a central role in the metabolic pathway of the parasite. In this work, a virtual screening of a library of novel thiadiazine derivatives against trypanothione reductase using molecular docking was performed. Four different series of hybrid ligands having in the structure one or two peptoid moieties (series I and II) or the tetrazole ring (series III and IV) were considered. An ad hoc numerical index called poses ratio was introduced to interpret the results of the docking analysis and to establish relevant structure-interaction relationships. In addition, six binding modes were found for the ligands with the highest populated conformational clusters after applying contact-based analysis. The most regular and relevant were binding modes I and II, found mainly for ligands from series I. A subsequent molecular docking on human glutathione reductase enzyme allowed to assess the possible cytotoxicity of the ligands towards human cells. A selective binding profile was found for ligands with interactions in the Hydrophobic cleft, the spermidine and the Z subsites inside the active site of trypanothione reductase. At the end of the study, new thiadiazine-based compounds were identified as plausible candidates to selectively inhibit the parasitic enzyme. Graphic abstract

30 September 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
MNMichael Niemeyer
Michael Niemeyer
ECElena Moreno Castillo
Elena Moreno Castillo
CIChristian H. Ihling
Christian H. Ihling
CIClaudio Iacobucci
Claudio Iacobucci
VWVerona Wilde
Verona Wilde
LVLuz Irina A. Calderón Villalobos
Luz Irina A. Calderón Villalobos
Cullin RING-type E3 ubiquitin ligases SCF TIR1/AFB1-5 and their ubiquitylation targets, AUX/IAAs, sense auxin concentrations in the nucleus. TIR1 binds a surface-exposed degron in AUX/IAAs promoting their ubiquitylation and rapid auxin-regulated proteasomal degradation. Here, we resolved TIR1·auxin·IAA7 and TIR1·auxin·IAA12 complex topology, and show that flexible intrinsically disordered regions (IDRs) in the degron’s vicinity, cooperatively position AUX/IAAs on TIR1. The AUX/IAA PB1 interaction domain also assists in non-native contacts, affecting AUX/IAA dynamic interaction states. Our results establish a role for IDRs in modulating auxin receptor assemblies. By securing AUX/IAAs on two opposite surfaces of TIR1, IDR diversity supports locally tailored positioning for targeted ubiquitylation, and might provide conformational flexibility for adopting a multiplicity of functional states. We postulate IDRs in distinct members of the AUX/IAA family to be an adaptive signature for protein interaction and initiation region for proteasome recruitment.

Verified
Conference Paper
Closed access
EMElena Moreno-Castillo
Elena Moreno-Castillo
BCBessy V. Cutiño-Avila
Bessy V. Cutiño-Avila
JSJorge Estrada Sarlabous
Jorge Estrada Sarlabous
VMVictoria Hernández Mederos
Victoria Hernández Mederos
AMAlberto Del Monte-Martínez
Alberto Del Monte-Martínez